Swanson et al. comment that opposition to assisted outpatient treatment arises from a range of consumer advocates and stakeholder resistance, omitting the resistance stemming from the absence of convincing evidence for their effectiveness. None of the three published randomized controlled trials of compulsory community treatment (3–5) found an advantage in their stated primary outcome of reduced readmissions. In addition, there are nearly a dozen controlled before and after studies (6) of the form. These are predominantly drawn from two large databases: New York, with 3,576 individuals in assisted outpatient treatment and 2,025 matched comparison subjects (7), and Victoria, Australia, with 8,879 individuals in assisted outpatient treatment (community treatment order) and 16,694 matched comparison subjects (8). Australian practice does not actively privilege intensive treatment for individuals in assisted outpatient treatment, and their findings are the opposite of those in New York. The Australian assisted treatment was associated with significantly increased admissions.